First-Line Immuno-Oncology Combination Therapies in Metastatic RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
First-Line Immuno-Oncology Combination Therapies in Metastatic Renal-Cell Carcinoma: Results From the International Metastatic Renal-Cell Carcinoma Database Consortium
Eur Urol 2019 Aug 22;[EPub Ahead of Print], S Dudani, J Graham, JC Wells, Z Bakouny, SK Pal, N Dizman, F Donskov, C Porta, G de Velasco, A Hansen, M Iafolla, B Beuselinck, UN Vaishampayan, LA Wood, E Liow, F Yan, T Yuasa, GA Bjarnason, TK Choueiri, DYC HengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.